6-chloro-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide1,1-dioxide-13CD2;6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-13C,d2-7-sulfonamide 1,1-Dioxide; Aquarius-13C,d2; Bremil-13C,d2; Cidrex-13C,d2; Dihydrochlorothiazide-13C,d2; Dichlotride-13C,d2; Diurizid-13C,d2; Drenol-13C,d2; Hidrochlortiazid-13C,d2; Hydrex-13C,d2; Oretic-13C,d2; Pantemon-13C,d2; Thiuretic-13C,d2;Hydrochlorothiazide-13C,d2
Hydrochlorothiazide-13C-d2 is a fully characterized chemical compound used as a reference standard of API Hydrochlorothiazide. The standard offered is compliant with regulatory guidelines. Hydrochlorothiazide-13C-d2 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1190006-03-1
![Picture of (N-[(2-Aminophenyl)sulfonyl] Acetamide)](https://bc3c83a0874864a50753-7010fd7f2bdf81ab41ee28479491701e.ssl.cf2.rackcdn.com/media//catalog/AR-H01180.jpg?size=256 "Show details for (N-[(2-Aminophenyl)sulfonyl] Acetamide)")
